HONG KONG – In a study led by Australian scientists at University of New South Wales (UNSW), introducing a beneficial natural mutation into blood cells using gene-editing was shown to stimulate production of fetal hemoglobin (Hb), a finding that could lead to a cure for blood diseases.
The structure of the human brain's cannabinoid receptor 1 (CB1), which binds to the main psychoactive ingredient in marijuana, delta 9-tetrahydrocannabinol (D9-THC), has been elucidated by Chinese researchers, which could have major implications for drug discovery and development.
The structure of the human brain's cannabinoid receptor 1 (CB1), which binds to the main psychoactive ingredient in marijuana, delta 9-tetrahydrocannabinol (D9-THC), has been elucidated by Chinese researchers, which could have major implications for drug discovery and development.
An international research collaboration has found a means to improve the effect of mimetics of the second mitochondrial-derived activator of caspase (Smac), a novel class of targeted cancer drugs that act by inducing apoptotic cancer cell death and inhibiting pro-survival signaling.
An international research collaboration has found a means to improve the effect of mimetics of the second mitochondrial-derived activator of caspase (Smac), a novel class of targeted cancer drugs that act by inducing apoptotic cancer cell death and inhibiting pro-survival signaling.
HONG KONG – Scientists at the Riken Brain Science Institute (BSI) have linked low levels of the neurotransmitter serotonin to the symptoms of autism spectrum disorder (ASD) in young mice, suggesting selective serotonin reuptake inhibitors (SSRIs) may have a role in treating autism in humans.
HONG KONG – Scientists at the Riken Brain Science Institute (BSI) have linked low levels of the neurotransmitter serotonin to the symptoms of autism spectrum disorder (ASD) in young mice, suggesting selective serotonin reuptake inhibitors (SSRIs) may have a role in treating autism in humans.
A new study by Japanese researchers has shown how the loss of a key mitochondrial protein facilitates progression of Parkinson's disease (PD), identifying a new therapeutic target and hence the potential for the discovery and development of new PD treatments.
